PURPOSE: Acquired immunity is impaired in hemodialysis (HD) patients, and decreased T cell number may contribute. Receptor activator of nuclear factor-κB ligand (RANKL) and osteoprotegerin (OPG) are expressed in cells of the immune system and affect T cell development, homeostasis and proliferation. Serum levels of RANKL and OPG and their relation to blood T cell number were evaluated in HD patients. METHODS: Thirty-four HD patients and 20 healthy controls participated in the study. Serum RANKL and OPG were measured by ELISA and T cell number was assessed by flow cytometry. RESULTS: Median RANKL concentration did not differ between HD patients and healthy volunteers (300.00 pmol/L; range, 3,340.00 vs. 330.00 pmol/L; range, 440.00 pmol/L; p = 0.528). Median OPG was markedly higher in HD patients than in healthy volunteers (13.12 ± 4.71 vs. 4.71 ± 0.93 pmol/L, p < 0.001). The T cell count was significantly lower in HD patients than in healthy controls (1,177.00 ± 567.71 vs. 1,519.80 ± 594.96 cells/mm(3), p = 0.044). In HD patients, blood T cell number was correlated positively with serum RANKL (ρ = 0.462, p = 0.007) and negatively to serum OPG (r = -0.449, p = 0.008). CONCLUSION: Serum OPG concentration is markedly increased in HD patients and may contribute to decreased blood T cell count and impaired acquired immunity that characterizes this population.
PURPOSE: Acquired immunity is impaired in hemodialysis (HD) patients, and decreased T cell number may contribute. Receptor activator of nuclear factor-κB ligand (RANKL) and osteoprotegerin (OPG) are expressed in cells of the immune system and affect T cell development, homeostasis and proliferation. Serum levels of RANKL and OPG and their relation to blood T cell number were evaluated in HDpatients. METHODS: Thirty-four HDpatients and 20 healthy controls participated in the study. Serum RANKL and OPG were measured by ELISA and T cell number was assessed by flow cytometry. RESULTS: Median RANKL concentration did not differ between HDpatients and healthy volunteers (300.00 pmol/L; range, 3,340.00 vs. 330.00 pmol/L; range, 440.00 pmol/L; p = 0.528). Median OPG was markedly higher in HDpatients than in healthy volunteers (13.12 ± 4.71 vs. 4.71 ± 0.93 pmol/L, p < 0.001). The T cell count was significantly lower in HDpatients than in healthy controls (1,177.00 ± 567.71 vs. 1,519.80 ± 594.96 cells/mm(3), p = 0.044). In HDpatients, blood T cell number was correlated positively with serum RANKL (ρ = 0.462, p = 0.007) and negatively to serum OPG (r = -0.449, p = 0.008). CONCLUSION: Serum OPG concentration is markedly increased in HDpatients and may contribute to decreased blood T cell count and impaired acquired immunity that characterizes this population.
Authors: A J Ashcroft; S M Cruickshank; P I Croucher; M J Perry; S Rollinson; J M Lippitt; J A Child; C Dunstan; P J Felsburg; G J Morgan; S R Carding Journal: Immunity Date: 2003-12 Impact factor: 31.745
Authors: T J Yun; M D Tallquist; A Aicher; K L Rafferty; A J Marshall; J J Moon; M E Ewings; M Mohaupt; S W Herring; E A Clark Journal: J Immunol Date: 2001-02-01 Impact factor: 5.422
Authors: D M Anderson; E Maraskovsky; W L Billingsley; W C Dougall; M E Tometsko; E R Roux; M C Teepe; R F DuBose; D Cosman; L Galibert Journal: Nature Date: 1997-11-13 Impact factor: 49.962
Authors: Simona W Rossi; Mi-Yeon Kim; Andreas Leibbrandt; Sonia M Parnell; William E Jenkinson; Stephanie H Glanville; Fiona M McConnell; Hamish S Scott; Josef M Penninger; Eric J Jenkinson; Peter J L Lane; Graham Anderson Journal: J Exp Med Date: 2007-05-14 Impact factor: 14.307
Authors: Juan C Duque; Laisel Martinez; Annia Mesa; Yuntao Wei; Marwan Tabbara; Loay H Salman; Roberto I Vazquez-Padron Journal: Surgery Date: 2015-05-18 Impact factor: 3.982